Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

The Sleeping Beauty (SB) transposase and its newly developed hyperactive variant, SB100X, are of increasing interest for genome modification in experimental models and gene therapy. The potential cytotoxicity of transposases requires careful assessment, considering that residual integration events o...

Full description

Saved in:
Bibliographic Details
Main Authors: Melanie Galla, Axel Schambach, Christine S. Falk, Tobias Maetzig, Johannes Kuehle, Kathrin Lange, Daniela Zychlinski, Niels Heinz, Martijn H. Brugman, Gudrun Göhring, Zsuzsanna Izsvák, Zoltán Ivics, Christopher Baum
Format: Artigo
Language:English
Published: 2011
Online Access:https://doi.org/10.1093/nar/gkr384
https://academic.oup.com/nar/article-pdf/39/16/7147/16775744/gkr384.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!